Empreendimentos Pague Menos (PGMN3) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 May, 2026Executive summary
Achieved 14.4% year-over-year gross revenue growth in Q1 2026, with 13% same-store sales growth, outpacing inflation by over 3x for the seventh consecutive quarter.
Net income reached R$55.6 million, more than quadrupling from Q1 2025, with net margin expanding by 0.9 percentage points.
EBITDA rose 36.1% year-over-year to R$204.7 million, marking the seventh consecutive quarter of over 30% EBITDA growth.
National market share expanded to 6.7%, with strong gains in the North and Northeast regions.
Digital channels accounted for 22.2% of sales, with omnichannel sales up 43.7% year-over-year.
Financial highlights
Gross margin improved by up to 0.8 percentage points year-over-year to 29.5%, aided by favorable product mix and commercial conditions.
SG&A expenses grew 13%, slightly below revenue growth, with a 0.1 percentage point dilution.
Net debt/EBITDA improved to 1.9x, reflecting deleveraging and improved capital allocation.
ROIC reached 21.2%, up 6.8 percentage points year-over-year.
Earnings per share hit an all-time high of R$0.50 (LTM).
Outlook and guidance
Pipeline of new stores supports gradual acceleration of organic growth for the remainder of the year.
Gross margin for the full year expected to be slightly lower than 2025, but EBITDA margin improvement remains a focus.
Continued focus on digital expansion, continuous care customer engagement, and operational efficiency to drive further margin and profitability gains.
Under-development projects include new store models, pricing policies, and private label reinvention.
Anticipate positive impact on margins from the new Paraíba distribution center starting Q3 2026.
Latest events from Empreendimentos Pague Menos
- Record 2025 growth in revenue, profit, and market share, with strong digital and operational gains.PGMN3
Q4 20252 Mar 2026 - Revenue and profit surged on strong sales, margin expansion, and synergy capture.PGMN3
Q2 20242 Feb 2026 - Record sales, margin gains, and lower leverage highlight strong operational momentum.PGMN3
Q3 202416 Jan 2026 - Record sales, margin expansion, and synergy capture drive robust growth and deleveraging.PGMN3
Q4 202419 Dec 2025 - Record sales and profit growth fueled by digital and operational gains.PGMN3
Q2 202523 Nov 2025 - Record revenue and EBITDA growth, digital acceleration, and market share gains in Q1 2025.PGMN3
Q1 202519 Nov 2025 - Record 18% revenue growth, 49.6% net income rise, and 6.7% market share in 3Q25.PGMN3
Q3 202513 Nov 2025 - Nationwide healthcare platform drives growth through digital innovation and health services expansion.PGMN3
Investor Presentation3 Jul 2025 - Nationwide Health Hub and digital innovation fuel PagueMenos extrafarma’s rapid, profitable growth.PGMN3
Investor Presentation16 Jun 2025